News & Updates

Show Multimedia Only

CAR T-cell therapy trumps standard care in earlier-line lymphoma

25 Dec 2021 by

Treatment with the CAR* T-cell therapy axicabtagene ciloleucel (axi-cel) in the curative setting significantly extends event-free survival (EFS) compared with standard of care (SOC) in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL), according to the ZUMA-7 study presented at ASH 2021.

25 Dec 2021

Apremilast proven safe, effective in mild to moderate psoriasis

25 Dec 2021

Treatment with apremilast appears safe and effective against mild to moderate plaque psoriasis, according to a recent study.

25 Dec 2021

Split-tablet equals alternating-day warfarin dosing

24 Dec 2021

Split-tablet and alternating-day dosing regimens of warfarin yield comparable outcomes such as the international normalized ratio, compliance, time in therapeutic range, and complications, a recent study has found.

24 Dec 2021

Sintilimab-IBI305-chemo improves PFS in EGFRm non-squamous NSCLC

24 Dec 2021 by

The combination of the anti-PD-1 monoclonal antibody sintilimab with the bevacizumab biosimilar IBI305 and pemetrexed and cisplatin chemotherapy improved progression-free survival (PFS) in patients with EGFR*-mutated (EGFRm) non-squamous non-small-cell lung cancer (NSCLC), according to interim analysis results of the phase III ORIENT-31 trial from China.

24 Dec 2021

Adjunctive ketamine safe, effective for sedation in ICU

24 Dec 2021

Sedation with adjunctive ketamine does not increase the percentage of Richmond Agitation-Sedation Scale (RASS) scores at goal relative to nonketamine sedatives (NKS), reveals a study.

24 Dec 2021

Statin adherence a must to reduce stroke risk among hyperlipidemia patients

24 Dec 2021

Patients with hyperlipidemia who take their statin medication as prescribed appear to do well, with treatment adherence conferring significant protection against the risk of ischaemic and haemorrhagic strokes, as reported in a study.

24 Dec 2021

Repeat surgery plus chemo may improve survival in recurrent ovarian cancer

23 Dec 2021 by

The DESKTOP* III trial has shown that patients whose ovarian cancer recurs have better overall survival (OS) following secondary cytoreductive surgery plus platinum-based chemotherapy compared with a platinum-based chemotherapy regimen alone.

23 Dec 2021

Mecobalamin plus vitamin E a good combo against recurrent mouth ulcer

23 Dec 2021

Combination treatment with mecobalamin tablets plus vitamin E soft capsules works in patients with recurrent oral ulcer, alleviating pain and improving the quality of life, according to a study.

23 Dec 2021